This unique mode of action operates in parallel to and independent of the direct cytolytic activities of NK cells37 and enables the eradication of MHC-deficient and IFN-unresponsive tumours that evade direct recognition and destruction by CD8+ cytolytic T cells (Extended Data Fig. 10). The gene discussed is IFNA1; the disease is neoplasm.